Biological control of vaginosis to improve reproductive health

Indian Journal of Medical Research

Volumn 140, Issue , 2014, Pages 91-97

  Mastromarino, Paola ^a   Hemalatha, R ^b   Barbonetti, A ^c   Cinque, B ^c   Cifone, M G ^c   Tammaro, F ^a   Francavilla, F ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NATIONAL INSTITUTE OF NUTRITION   (India)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Bacterial vaginosis; Lactobacilli; Probiotics; Reproductive health; Vaginal microbiota

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 8; PROBIOTIC AGENT;

CANDIDA ALBICANS; DISEASE ASSOCIATION; DISEASE TRANSMISSION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE FERTILITY; FERTILIZATION; HUMAN; INFECTION CONTROL; NONHUMAN; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PUBLIC HEALTH; REPRODUCTIVE HEALTH; REVIEW; SEXUALLY TRANSMITTED DISEASE; STAPHYLOCOCCUS EPIDERMIDIS; URINARY TRACT INFECTION; VAGINA FLORA; VAGINITIS; COMPLICATION; DRUG EFFECTS; FEMALE; FEMALE INFERTILITY; GENETICS; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY; STANDARDS; VAGINA; VAGINOSIS, BACTERIAL;

FEMALE; FERTILIZATION; HUMANS; INFERTILITY, FEMALE; MICROBIOTA; PREGNANCY; PROBIOTICS; REPRODUCTIVE HEALTH; VAGINA; VAGINOSIS, BACTERIAL;

EID: 84922053570     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Rönnqvist PD, Forsgren-Brusk UB, Grahn-Håkansson EE. Lactobacilli in the female genital tract in relation to other genital microbes and vaginal pH. Acta Obstet Gynecol Scand 2006; 85: 726-35.
2. Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 2007; 109: 114-20.
3. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005; 353: 1899-911.
4. Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 2004; 190: 1509-19.
5. Koumans EH, Markowitz LE, Hogan V; CDC BV Working Group. Indications for therapy and treatment recommendations for bacterial vaginosis in non-pregnant and pregnant women: a synthesis of data. Clin infect Dis 2002; 35 (Suppl 2): S152-72.
6. Harmanli OH, Cheng GY, Nyirjesy P, Chatwani A, Gaughan JP. Urinary tract infections in women with bacterial vaginosis. Obstet Gynecol 2000; 95: 710-2.
7. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180: 1863-8.
8. Wiesenfeld H, Hillier S, Krohn MA, Landers DV, Sweet RL. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 2003; 36: 663-8.
9. Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003; 37: 319-25.
10. Pellati D, Mylonakis I, Bertoloni G, Fiore C, Andrisani A, Ambrosini G, et al. Genital tract infections and infertility. Eur J Obstet Gynecol Reprod Biol 2008; 140: 3-11.
11. Workowski KA, Berman SM. Centers for Disease Control and Prevention Sexually Transmitted Disease Treatment Guidelines. Clin Infect Dis 2011; 53 (Suppl 3): S59-63.
12. Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006; 193: 1478-86.
13. Sobel JD, Ferris D, Schwebke J, Nyirjesy P, Wiesenfeld HC, Peipert J, et al. Suppressive antibacterial therapy with 0. 75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006; 194: 1283-9.
14. Bayer AS, Chow AW, Concepcion N, Guze LB. Susceptibility of 40 lactobacilli to six antimicrobial agents with broad grampositive anaerobic spectra. Antimicrob Agents Chemother 1978; 14: 720-2.
15. Beigi RH, Austin MN, Meyn LA, Krohn MA, Hillier SL. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 2004; 191: 1124-9.
16. Mastromarino P, Vitali B, Mosca L. Bacterial vaginosis: a review on clinical trials with probiotics. New Microbiol 2013; 36: 229-38.
17. Maggi L, Mastromarino P, Macchia S, Brigidi P, Pirovano F, Matteuzzi D. Technological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administration. Eur J Pharm Biopharm 2000; 50: 389-95.
18. Mastromarino P, Brigidi P, Macchia S, Maggi L, Pirovano F, Trinchieri V, et al. Characterization and selection of vaginal Lactobacillus containing strains for the preparation of vaginal tablets. J Appl Microbiol 2002; 93: 884-93.
19. Mastromarino P, Macchia S, Meggiorini L, Trinchieri V, Mosca L, Perluigi M, et al. Effectiveness of Lactobacillus containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin Microbiol Infect 2009; 15: 67-74.
20. Larsson PG, Stray-Pedersen B, Ryttig KR, Larsen S. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health 2008; 8: 3.
21. Ya W, Reifer C, Miller LE. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. Am J Obstet Gynecol 2010; 203: 120. e1-6.
22. Spandorfer SD, Neuer A, Giraldo PC, Rosenwaks Z, Witkin SS. Relationship of abnormal vaginal flora, proinflammatory cytokines and idiopathic infertility in women undergoing IVF. J Reprod Med 2001; 46: 806-10.
23. Hemalatha R, Mastromarino P, Ramalaxmi BA, Balakrishna NV, Sesikeran B. Effectiveness of vaginal tablets containing lactobacilli versus pH tablets on vaginal health and inflammatory cytokines: a randomized, double-blind study. Eur J Clin Microbiol Infect Dis 2012; 31: 3097-105.
24. Fujita Y, Mihara T, Okazaki T, Shitanaka M, Kushino R, Ikeda C, et al. Toll-like receptors (TLR) 2 and 4 on human sperm recognize bacterial endotoxins and mediate apoptosis. Hum Reprod 2011; 26: 2799-806.
25. Casari E, Ferrario A, Morenghi E, Montanelli A. Gardnerella, Trichomonas vaginalis, Candida, Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum in the genital discharge of symptomatic fertile and asymptomatic infertile women. New Microbiol 2010; 33: 69-76.
26. Nardis C, Mosca L, Mastromarino P. Vaginal microbiota and viral sexually transmitted diseases. Ann Ig 2013; 25: 443-56.
27. Barbonetti A, Cinque B, Vassallo MR, Mineo S, Francavilla S, Cifone MG, et al. Effect of vaginal probiotic lactobacilli on in vitro-induced sperm lipid peroxidation and its impact on sperm motility and viability. Fertil Steril 2011; 95: 2485-8.
28. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51: 1-78.
29. Dugoua JJ, Machado M, Zhu X, Chen X, Koren G, Einarson TR. Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, bifidobacterium, and Saccharomyces spp. J Obstet Gynaecol Can 2009; 31: 542-52.
30. Elias J, Bozzo P, Einarson A. Are probiotics safe for use during pregnancy and lactation? Can Fam Physician 2011; 57: 299-301.
31. Vitali B, Cruciani F, Baldassarre ME, Capursi T, Spisni E, Valerii MC, et al. Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion. BMC Microbiol 2012; 12: 236.
32. Conti C, Malacrino C, Mastromarino P. Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. J Physiol Pharmacol 2009; 60 (Suppl 6): 19-26.
33. Mastromarino P, Cacciotti F, Masci A, Mosca L. Antiviral activity of Lactobacillus brevis towards herpes simplex virus type 2: role of cell wall associated components. Anaerobe 2011; 17: 334-6.